Cargando…
Updates in the Diffuse Large B-Cell Lymphoma Treatment Landscape
During JADPRO Live Virtual 2021, presenters discussed updates in the treatment of diffuse large B-cell lymphoma (DLBCL), including novel agents and chimeric antigen receptor (CAR) T-cell therapy, and how the treatment and management of patients with DLBCL has been affected by the COVID-19 pandemic.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126354/ https://www.ncbi.nlm.nih.gov/pubmed/35663173 http://dx.doi.org/10.6004/jadpro.2022.13.3.33 |